LeMaitre Vascular, Inc. (LMAT)
Market Cap | 2.08B |
Revenue (ttm) | 213.03M |
Net Income (ttm) | 41.32M |
Shares Out | 22.48M |
EPS (ttm) | 1.82 |
PE Ratio | 50.87 |
Forward PE | 44.24 |
Dividend | $0.64 (0.69%) |
Ex-Dividend Date | Nov 21, 2024 |
Volume | 55,644 |
Open | 91.00 |
Previous Close | 91.38 |
Day's Range | 90.83 - 92.63 |
52-Week Range | 52.88 - 109.58 |
Beta | 0.93 |
Analysts | Buy |
Price Target | 92.83 (+0.22%) |
Earnings Date | Oct 31, 2024 |
About LMAT
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The ... [Read more]
Financial Performance
In 2023, LeMaitre Vascular's revenue was $193.48 million, an increase of 19.69% compared to the previous year's $161.65 million. Earnings were $30.11 million, an increase of 45.89%.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for LMAT stock is "Buy." The 12-month stock price forecast is $92.83, which is an increase of 0.22% from the latest price.
News
LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering
BOSTON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (“LeMaitre”) (Nasdaq: LMAT) today announced its intention to offer, subject to market and other conditions, $150,000,000 aggregate pri...
Final Trade: LMAT, GOOGL, IBM, GILD
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
LeMaitre to Participate at Upcoming Investor Conferences in December
BURLINGTON, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in December.
LeMaitre Vascular: The Market Is Catching On To This Dividend Growth Story
LeMaitre continues to expand in the peripheral vascular disease market, with recent revenue gains driven by premium pricing and international growth. Its strong dividend growth of 14.3% this year and ...
LeMaitre to Participate at Upcoming Investor Conferences in November
BURLINGTON, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November.
LeMaitre Vascular, Inc. (LMAT) Q3 2024 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q3 2024 Earnings Conference Call October 33, 2024 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chief Executive Off...
LeMaitre Q3 2024 Financial Results
BURLINGTON, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and services, reported Q3 2024 results, announced a $0.16/share quarterly dividen...
LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024
BURLINGTON, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2024 financial results on Thursday, October 31, 2024, ...
LeMaitre to Participate at Upcoming Investor Conferences in September
BURLINGTON, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in September.
LeMaitre Vascular, Inc. (LMAT) Q2 2024 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q2 2024 Results Conference Call August 1, 2024 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chief Executive Office...
LeMaitre Q2 2024 Financial Results
BURLINGTON, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2024 results, announced a $0.16/share quarterly di...
LeMaitre Vascular: A Small Cap With Best-In-Industry Growth
I outline why LeMaitre Vascular is my top choice in the Health Care Equipment industry and one of the best small caps in the sector. LeMaitre has shown incredible revenue and EPS growth since its IPO ...
LeMaitre Will Announce Second Quarter 2024 Earnings Results August 1, 2024
BURLINGTON, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2024 financial results on Thursday, August 1, 2024, a...
LeMaitre: Further Upsides Supported By Longer Competitive Advantage Period
LeMaitre is a long-term compounder with mouth-watering economics and shareholder-friendly management. LMAT shares have rallied 45% since August '23, with increased dividends and improving fundamentals...
Sell In May And Go Away? - April Dividend Income Report
Many investors believe the stock market generates a better return between November and April than between May and October. Many events contributed to convincing investors that summer and the beginning...
LeMaitre to Present at the Jefferies Global Healthcare Conference
BURLINGTON, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that George W. LeMaitre, Chairman & CEO, will present at the 2024 Jefferies Global Healthcare ...
LeMaitre Vascular, Inc. (LMAT) Q1 2024 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2024 Earnings Conference Call May 2, 2024 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chief Executive Officer ...
LeMaitre Q1 2024 Financial Results
BURLINGTON, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2024 results, announced a $0.16/share quarterly div...
LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024
BURLINGTON, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2024 financial results on Thursday, May 2, 2024, afte...
LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference
BURLINGTON, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present virtually at the 23rd Annual Needh...
LeMaitre to Participate at Upcoming Investor Conferences in March
BURLINGTON, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March.
LeMaitre Vascular, Inc. (LMAT) Q4 2023 Earnings Call Transcript
LeMaitre Vascular, Inc. (LMAT) Q4 2023 Earnings Call Transcript
LeMaitre Q4 2023 Financial Results
BURLINGTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2023 results, announced a $0.16/share quarterly di...